Log has written
THURSDAY, NOVEMBER 26, 2009
Paonta Sahib
  
FDA is reviewing Ranbaxy’s corrective plan on US drugs
Catherine Larkin and Saikat Chatterjee / Bloomberg  01:08 AM | May 29,2009
The Food and Drug Administration is working very closely with the firm to ensure that all the Ranbaxy products currently in the US market are safe and effective
Ranbaxy’s Paonta Sahib unit gets UK, Australia approvals
Radhieka Pandeya   10:26 PM | March 23,2009
This follows an action by the US Food and Drugs Administration, which on 25 February suspended review of all approval applications from the plant on charges of falsifying data and test results
Ranbaxy shares continue to fall; Canada regulator takes action
Radhieka Pandeya and C.H. Unnikrishnan  12:22 AM | February 28,2009
India’s drug industry is concerned this could mean slower drug approvals for other pharma companies
FDA charges roil Ranbaxy, Daiichi stocks
Radhieka Pandeya   11:39 PM | February 26,2009
Ranbaxy shares fell as much as 18% to close at Rs169.95 on the BSE & shares of Daiichi Sankyo, which acquired Ranbaxy last year, fell 9.5% to 1,680 yen on the Tokyo Stock Exchange
US FDA says Ranbaxy plant falsified data
Reuters  10:40 PM | February 25,2009
The Food and Drug Administration said it halted reviews of drug applications from Ranbaxy’s Paonta Sahib plant in India
Copyright © 2009 HT Media All Rights Reserved